Literature DB >> 15082703

Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.

E Wesley Ely1, Ayumi Shintani, Brenda Truman, Theodore Speroff, Sharon M Gordon, Frank E Harrell, Sharon K Inouye, Gordon R Bernard, Robert S Dittus.   

Abstract

CONTEXT: In the intensive care unit (ICU), delirium is a common yet underdiagnosed form of organ dysfunction, and its contribution to patient outcomes is unclear.
OBJECTIVE: To determine if delirium is an independent predictor of clinical outcomes, including 6-month mortality and length of stay among ICU patients receiving mechanical ventilation. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study enrolling 275 consecutive mechanically ventilated patients admitted to adult medical and coronary ICUs of a US university-based medical center between February 2000 and May 2001. Patients were followed up for development of delirium over 2158 ICU days using the Confusion Assessment Method for the ICU and the Richmond Agitation-Sedation Scale. MAIN OUTCOME MEASURES: Primary outcomes included 6-month mortality, overall hospital length of stay, and length of stay in the post-ICU period. Secondary outcomes were ventilator-free days and cognitive impairment at hospital discharge.
RESULTS: Of 275 patients, 51 (18.5%) had persistent coma and died in the hospital. Among the remaining 224 patients, 183 (81.7%) developed delirium at some point during the ICU stay. Baseline demographics including age, comorbidity scores, dementia scores, activities of daily living, severity of illness, and admission diagnoses were similar between those with and without delirium (P>.05 for all). Patients who developed delirium had higher 6-month mortality rates (34% vs 15%, P =.03) and spent 10 days longer in the hospital than those who never developed delirium (P<.001). After adjusting for covariates (including age, severity of illness, comorbid conditions, coma, and use of sedatives or analgesic medications), delirium was independently associated with higher 6-month mortality (adjusted hazard ratio [HR], 3.2; 95% confidence interval [CI], 1.4-7.7; P =.008), and longer hospital stay (adjusted HR, 2.0; 95% CI, 1.4-3.0; P<.001). Delirium in the ICU was also independently associated with a longer post-ICU stay (adjusted HR, 1.6; 95% CI, 1.2-2.3; P =.009), fewer median days alive and without mechanical ventilation (19 [interquartile range, 4-23] vs 24 [19-26]; adjusted P =.03), and a higher incidence of cognitive impairment at hospital discharge (adjusted HR, 9.1; 95% CI, 2.3-35.3; P =.002).
CONCLUSION: Delirium was an independent predictor of higher 6-month mortality and longer hospital stay even after adjusting for relevant covariates including coma, sedatives, and analgesics in patients receiving mechanical ventilation.

Entities:  

Mesh:

Year:  2004        PMID: 15082703     DOI: 10.1001/jama.291.14.1753

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  753 in total

1.  Identifying elements of ICU care that families report as important but unsatisfactory: decision-making, control, and ICU atmosphere.

Authors:  Tristan R Osborn; J Randall Curtis; Elizabeth L Nielsen; Anthony L Back; Sarah E Shannon; Ruth A Engelberg
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

2.  Postoperative delirium: a 76-year-old woman with delirium following surgery.

Authors:  Edward R Marcantonio
Journal:  JAMA       Date:  2012-07-04       Impact factor: 56.272

3.  The association between acute respiratory distress syndrome, delirium, and in-hospital mortality in intensive care unit patients.

Authors:  S Jean Hsieh; Graciela J Soto; Aluko A Hope; Ana Ponea; Michelle N Gong
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

4.  The effect of cognitive impairment on the accuracy of the presenting complaint and discharge instruction comprehension in older emergency department patients.

Authors:  Jin H Han; Suzanne N Bryce; E Wesley Ely; Sunil Kripalani; Alessandro Morandi; Ayumi Shintani; James C Jackson; Alan B Storrow; Robert S Dittus; John Schnelle
Journal:  Ann Emerg Med       Date:  2011-01-26       Impact factor: 5.721

5.  The Confusion Assessment Method for the ICU-7 Delirium Severity Scale: A Novel Delirium Severity Instrument for Use in the ICU.

Authors:  Babar A Khan; Anthony J Perkins; Sujuan Gao; Siu L Hui; Noll L Campbell; Mark O Farber; Linda L Chlan; Malaz A Boustani
Journal:  Crit Care Med       Date:  2017-05       Impact factor: 7.598

Review 6.  Delirium: a focused review.

Authors:  Howard S Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

7.  Corticosteroids and transition to delirium in patients with acute lung injury.

Authors:  Matthew P Schreiber; Elizabeth Colantuoni; Oscar J Bienvenu; Karin J Neufeld; Kuan-Fu Chen; Carl Shanholtz; Pedro A Mendez-Tellez; Dale M Needham
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

8.  Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals.

Authors:  Rina P Patel; Meredith Gambrell; Theodore Speroff; Theresa A Scott; Brenda T Pun; Joyce Okahashi; Cayce Strength; Pratik Pandharipande; Timothy D Girard; Hayley Burgess; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

9.  Comparison of the confusion assessment method for the intensive care unit (CAM-ICU) with the Intensive Care Delirium Screening Checklist (ICDSC) for delirium in critical care patients gives high agreement rate(s).

Authors:  Konstanze Plaschke; Rebecca von Haken; Mirijam Scholz; Ria Engelhardt; Angelika Brobeil; Eike Martin; Markus A Weigand
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

10.  Benzodiazepines and Development of Delirium in Critically Ill Children: Estimating the Causal Effect.

Authors:  Kalgi Mody; Savneet Kaur; Elizabeth A Mauer; Linda M Gerber; Bruce M Greenwald; Gabrielle Silver; Chani Traube
Journal:  Crit Care Med       Date:  2018-09       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.